Table 3.
pAkt Thr308 | pAkt Ser473 | pAMPK Thr172 | pACC Ser227 | |
---|---|---|---|---|
Basal | 100±8.9 | 100±11 | 100±29 | 100±11 |
AICAR | 148±16* | 174±41* | 266±17** | 520±27** |
Basal | 124±26 | 113±13 | 101±15 | 120±21 |
Insulin | 1,989±207**‡ | 2,726±215**‡ | 98.3±7.6 | 124±14 |
Basal | 84.0±15 | 90.1±12 | 96.8±13 | 127±23 |
AICAR + insulin | 1,962±168** | 2,641±182** | 279±9.8** | 596±35** |
Basal | 115±20 | 84.8±6.9 | 125±28 | 124±19 |
Contraction | 246±29* | 287±23** | 489±32**§ | 476±20** |
Basal | 133±18 | 95.8±18 | 93.4±18 | 112±11 |
Insulin + contraction | 1,758±159** | 2,413±200** | 486±57** | 469±42** |
Basal | 102±14 | 77.1±11 | 88.5±14 | 132±18 |
AICAR + contraction | 274±42* | 336±47* | 454±47**a | 641±38**¤ |
Data are related to basal from AICAR trial and expressed as means ± SE; n = 8. Thr308 and Ser473: increase in phosphorylation was higher in insulin-stimulated muscle than AICAR- or contraction-stimulated muscle (‡P < 0.05). Combining insulin and AICAR or contraction did not increase phosphorylation above insulin levels. pAMPK Thr172: contraction increased phosphorylation to a higher extent than AICAR (§P < 0.05); combining AICAR and contraction increased phosphorylation above AICAR (‡P < 0.05) but not contraction levels. pACC Ser227: AICAR and contraction combined increased phosphorylation to a higher extent than AICAR or contraction alone (aP < 0.05).
P < 0.05/0.01 toward basal.